Promacta 12.5 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MU4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $109,569
Award facts
- Contract value 100% obligated
- $109,568.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $109,568.65 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on January 26, 2026, with an ultimate completion date of February 17, 2026, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA Troop Support Medical contract enables the delivery of a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This delivery order for Promacta demonstrates the company's ongoing role in supporting Defense Health Agency requirements and reflects the efficiency of the indefinite delivery contract vehicle in rapidly fulfilling government pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26F9MU4?
SPE2DR26F9MU4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F9MU4 worth?
The government has obligated $109,569 on SPE2DR26F9MU4.
Is contract SPE2DR26F9MU4 an order under another contract?
Yes. SPE2DR26F9MU4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MU4 competed?
The extent of competition for SPE2DR26F9MU4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award